| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
dyskerin pseudouridine synthase 1 | 0.547 | 0.769 | 1.00 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
NLR family pyrin domain containing 1 | 0.502 | 0.769 | 5.0E-19 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
R-spondin 1 | 0.593 | 0.731 | 1.4E-06 |
|
group | 0.100 | None | 0 | 0 | |||||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
group | 0.100 | None | 1.000 | 43 | 0 | 1975 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 1979 | 2017 | ||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1979 | 2008 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1979 | 2017 | ||||||||
|
CYP3A7-CYP3A51P readthrough | 0.821 | 0.154 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1979 | 1979 | |||||||||
|
cytochrome P450 family 3 subfamily A member 7 | 0.670 | 0.500 | 6.1E-14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1979 | 1979 | ||||||||
|
cytochrome P450 family 3 subfamily A member 5 | 0.511 | 0.846 | 6.3E-17 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1979 | 1979 | ||||||||
|
arylsulfatase A | 0.448 | 0.923 | 1.1E-11 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1981 | 1981 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.957 | 70 | 4 | 1982 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.400 | None | 0.962 | 52 | 2 | 1983 | 2019 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 1983 | 2019 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1983 | 2015 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.969 | 130 | 1 | 1984 | 2020 | ||||||||
|
SEC14 like lipid binding 2 | 0.494 | 0.885 | 2.9E-08 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 1984 | 2009 | ||||||||
|
LDL receptor related protein associated protein 1 | 0.579 | 0.731 | 4.5E-07 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 1984 | 1990 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
group | 0.100 | None | 1.000 | 39 | 0 | 1985 | 2018 | ||||||||
|
CEA cell adhesion molecule 3 | 0.494 | 0.731 | 1.1E-09 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 1986 | 2019 | ||||||||
|
CEA cell adhesion molecule 7 | 0.494 | 0.769 | 1.3E-07 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 1986 | 2019 | ||||||||
|
pregnancy specific beta-1-glycoprotein 2 | 0.492 | 0.731 | 1.4E-30 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 1986 | 2019 | ||||||||
|
endogenous retrovirus group W member 4 | 0.686 | 0.615 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1986 | 1986 | |||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
group | 0.100 | None | 1.000 | 22 | 0 | 1987 | 2005 | ||||||||
|
furin, paired basic amino acid cleaving enzyme | 0.612 | 0.769 | 1.00 |
|
group | 0.310 | None | 1.000 | 3 | 0 | 1987 | 2005 |